ExploreWatchlistsPricing
  1. JP-listed companies
  2. TORII PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Total liabilities

TORII PHARMACEUTICAL CO., LTD. (E00934)

Market cap
P/E ratio
Torii Pharmaceutical manufactures and sells prescription medicines for kidney disease, skin conditions, allergies, and other medical needs in Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Dec 31, 202419,130+43.86%
Dec 31, 202313,298-8.06%
Dec 31, 202214,464+4.85%
Dec 31, 202113,795+26.15%
Dec 31, 202010,935-59.22%
Dec 31, 201926,817+62.99%
Dec 31, 201816,453-6.63%
Dec 31, 201717,622+17.72%
Dec 31, 201614,969-6.69%
Dec 31, 201516,042+30.17%
Dec 31, 201412,324

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat